TY  - GEN
AU  - Zhang,Wenyong W
AU  - Cortes,Jorge E
AU  - Yao,Hui
AU  - Zhang,Li
AU  - Reddy,Neelima G
AU  - Jabbour,Elias
AU  - Kantarjian,Hagop M
AU  - Jones,Dan
TI  - Predictors of primary imatinib resistance in chronic myelogenous leukemia are distinct from those in secondary imatinib resistance
SN  - 1527-7755
PY  - 2009///0820
KW  - Analysis of Variance
KW  - Benzamides
KW  - Blast Crisis
KW  - genetics
KW  - Cohort Studies
KW  - DNA Mutational Analysis
KW  - Drug Resistance, Neoplasm
KW  - drug effects
KW  - Female
KW  - Follow-Up Studies
KW  - Gene Expression Regulation, Neoplastic
KW  - Genes, abl
KW  - Humans
KW  - Imatinib Mesylate
KW  - Leukemia, Myelogenous, Chronic, BCR-ABL Positive
KW  - drug therapy
KW  - Male
KW  - Mutation
KW  - Pharmacogenetics
KW  - Piperazines
KW  - administration & dosage
KW  - Probability
KW  - Protein Kinase Inhibitors
KW  - Pyrimidines
KW  - Retrospective Studies
KW  - Risk Assessment
KW  - Severity of Illness Index
KW  - Survival Analysis
KW  - Treatment Outcome
N1  - Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1200/JCO.2008.19.4076
ER  -